Genesis Growth Tech Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to focus its efforts on identifying technology companies operating primarily within the consumer internet industry in Europe, Israel, the United Arab Emirates, or the United States. The company was incorporated in 2021 and is based in Hergiswil, Switzerland.
IPO Year: 2022
Exchange: NASDAQ
| Date | Price Target | Rating | Analyst |
|---|
PRER14A - Genesis Growth Tech Acquisition Corp. (0001865697) (Filer)
PREM14A - Genesis Growth Tech Acquisition Corp. (0001865697) (Filer)
425 - Genesis Growth Tech Acquisition Corp. (0001865697) (Subject)
8-K - Genesis Growth Tech Acquisition Corp. (0001865697) (Filer)
425 - Genesis Growth Tech Acquisition Corp. (0001865697) (Subject)
8-K - Genesis Growth Tech Acquisition Corp. (0001865697) (Filer)
25-NSE - Genesis Growth Tech Acquisition Corp. (0001865697) (Subject)
10-Q - Genesis Growth Tech Acquisition Corp. (0001865697) (Filer)
8-K - Genesis Growth Tech Acquisition Corp. (0001865697) (Filer)
DEFA14A - Genesis Growth Tech Acquisition Corp. (0001865697) (Filer)
NIDWALDEN, Switzerland, July 14, 2023 (GLOBE NEWSWIRE) -- Genesis Growth Tech Acquisition Corp. (NASDAQ:GGAA) ("GGAA" or "Genesis"), today announced that on July 14, 2023, it received a notice ("Notice") from the Listing Qualifications Department of The Nasdaq Stock Market ("Nasdaq"). The Notice advised the Company that for the 30 consecutive trading days ending June 27, 2023, the Company's average market value of listed securities has been below $50 million and the average market value of publicly held securities for its Class A ordinary shares has been below $40 million, and as a result, the Company was not in compliance with Nasdaq Listing Rule 5452 and that Nasdaq has determined to del
NIDWALDEN, Switzerland, May 22, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Genesis Growth Tech Acquisition Corp., (NASDAQ:GGAA), a special purpose acquisition company, and NextTrip Holdings, Inc., a travel technology incubator based in Sunrise, Florida ("NextTrip"), announced today that they have entered into a definitive Agreement and Plan of Merger (the "Merger Agreement") that, upon closing, will provide the opportunity for NextTrip to become a publicly traded company on NASDAQ. NextTrip is a travel technology company that specializes in using proprietary technology, analytics, and strategic partnerships to provide specialized travel solutions in leisure, wellness, and business travel.
NIDWALDEN, Switzerland, April 21, 2023 (GLOBE NEWSWIRE) -- Genesis Growth Tech Acquisition Corp. (NASDAQ:GGAA) ("GGAA" or "Genesis"), announced today that it had received a notification letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") stating GGAA was not in compliance with Nasdaq Listing Rule 5250(c)(1), as a result of not having timely filed its Annual Report on Form 10-K for the year ended December 31, 2022. The Nasdaq notification letter has no immediate effect on the listing of the Company's units, common stock or warrants on The Nasdaq Global Market. The Nasdaq notification letter provides the Company 60 calendar days from the date of the n
BERNAY, France and NIDWALDEN, Switzerland, Sept. 08, 2022 (GLOBE NEWSWIRE) -- Biolog-id, a digital health solution provider focusing on value-chain optimization, and Genesis Growth Tech Acquisition Corp. (NASDAQ:GGAA) ("GGAA" or "Genesis"), a special purpose acquisition company, have executed the business combination agreement (the "BCA") in relation to their proposed merger. The boards of directors of both Biolog-id and Genesis have unanimously approved the BCA. "It took creativity, patience, and persistence to take Biolog-id from an innovative idea to a functioning solution to a viable global business," said Jean-Claude Mongrenier, founder, shareholder, and Chairman of the Biolog-id Bo
BERNAY, France and NIDWALDEN, Switzerland , Aug. 23, 2022 (GLOBE NEWSWIRE) -- Biolog-id, a digital health solution provider focusing on value-chain optimization, and Genesis Growth Tech Acquisition Corp. (NASDAQ:GGAA) ("GGAA" or "Genesis"), a special purpose acquisition company, today announced that the companies have entered into a memorandum of understanding in connection with a proposed merger of Biolog-id and Genesis (the "MoU"). Pursuant to the MoU, and in accordance with applicable French law, the parties have agreed to initiate a consultation with the social and economic committee (comité social et économique) of Biolog-id concerning the proposed merger. To facilitate the consu
SC 13G/A - Genesis Growth Tech Acquisition Corp. (0001865697) (Subject)
SC 13G/A - Genesis Growth Tech Acquisition Corp. (0001865697) (Subject)
SC 13G - Genesis Growth Tech Acquisition Corp. (0001865697) (Subject)
SC 13G/A - Genesis Growth Tech Acquisition Corp. (0001865697) (Subject)
SC 13G/A - Genesis Growth Tech Acquisition Corp. (0001865697) (Subject)
SC 13G/A - Genesis Growth Tech Acquisition Corp. (0001865697) (Subject)
SC 13G - Genesis Growth Tech Acquisition Corp. (0001865697) (Subject)
SC 13G - Genesis Growth Tech Acquisition Corp. (0001865697) (Subject)
SC 13G/A - Genesis Growth Tech Acquisition Corp. (0001865697) (Subject)
SC 13G - Genesis Growth Tech Acquisition Corp. (0001865697) (Subject)